Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1961 1
1962 2
1963 4
1964 2
1965 2
1966 4
1967 4
1968 6
1969 3
1970 2
1971 7
1972 5
1974 3
1975 6
1976 6
1977 5
1978 10
1979 11
1980 16
1981 15
1982 14
1983 18
1984 18
1985 13
1986 20
1987 17
1988 20
1989 24
1990 18
1991 25
1992 30
1993 27
1994 29
1995 36
1996 31
1997 32
1998 42
1999 46
2000 42
2001 29
2002 30
2003 42
2004 42
2005 40
2006 59
2007 48
2008 46
2009 53
2010 64
2011 74
2012 92
2013 90
2014 65
2015 62
2016 56
2017 75
2018 81
2019 71
2020 77
2021 30
Text availability
Article attribute
Article type
Publication date

Search Results

1,702 results
Results by year
Filters applied: . Clear all
Page 1
In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria.
Ito A, Sato T, Ota M, Takemura M, Nishikawa T, Toba S, Kohira N, Miyagawa S, Ishibashi N, Matsumoto S, Nakamura R, Tsuji M, Yamano Y. Ito A, et al. Among authors: tsuji m. Antimicrob Agents Chemother. 2017 Dec 21;62(1):e01454-17. doi: 10.1128/AAC.01454-17. Print 2018 Jan. Antimicrob Agents Chemother. 2017. PMID: 29061741 Free PMC article.
Meat consumption and colorectal cancer risk in Japan: The Takayama study.
Wada K, Oba S, Tsuji M, Tamura T, Konishi K, Goto Y, Mizuta F, Koda S, Hori A, Tanabashi S, Matsushita S, Tokimitsu N, Nagata C. Wada K, et al. Among authors: tsuji m. Cancer Sci. 2017 May;108(5):1065-1070. doi: 10.1111/cas.13217. Epub 2017 May 16. Cancer Sci. 2017. PMID: 28256076 Free PMC article.
Heterogeneity in gut microbiota drive polyphenol metabolism that influences α-synuclein misfolding and toxicity.
Ho L, Zhao D, Ono K, Ruan K, Mogno I, Tsuji M, Carry E, Brathwaite J, Sims S, Frolinger T, Westfall S, Mazzola P, Wu Q, Hao K, Lloyd TE, Simon JE, Faith J, Pasinetti GM. Ho L, et al. Among authors: tsuji m. J Nutr Biochem. 2019 Feb;64:170-181. doi: 10.1016/j.jnutbio.2018.10.019. Epub 2018 Nov 14. J Nutr Biochem. 2019. PMID: 30530257 Free PMC article.
In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan.
Hsueh SC, Lee YJ, Huang YT, Liao CH, Tsuji M, Hsueh PR. Hsueh SC, et al. Among authors: tsuji m. J Antimicrob Chemother. 2019 Feb 1;74(2):380-386. doi: 10.1093/jac/dky425. J Antimicrob Chemother. 2019. PMID: 30357343
Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT.
Matsui H, Arai Y, Imoto H, Mitsuyoshi T, Tamura N, Kondo T, Kanda J, Ishikawa T, Imada K, Ueda Y, Toda Y, Anzai N, Yago K, Nohgawa M, Yonezawa A, Tsunemine H, Itoh M, Yamamoto K, Tsuji M, Moriguchi T, Takaori-Kondo A; Kyoto Stem Cell Transplantation Group (KSCTG). Matsui H, et al. Among authors: tsuji m. Blood Adv. 2020 Jul 14;4(13):3169-3179. doi: 10.1182/bloodadvances.2020002007. Blood Adv. 2020. PMID: 32658984 Free PMC article.
In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
Kazmierczak KM, Tsuji M, Wise MG, Hackel M, Yamano Y, Echols R, Sahm DF. Kazmierczak KM, et al. Among authors: tsuji m. Int J Antimicrob Agents. 2019 Feb;53(2):177-184. doi: 10.1016/j.ijantimicag.2018.10.007. Epub 2018 Oct 26. Int J Antimicrob Agents. 2019. PMID: 30395986 Free article.
1,702 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page